These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 23206979)

  • 61. Carotid intima-media thickness in polycystic ovary syndrome and its association with hormone and lipid profiles.
    Jabbour R; Ott J; Eppel W; Frigo P
    PLoS One; 2020; 15(4):e0232299. PubMed ID: 32330202
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Elevated fasting insulin is associated with cardiovascular and metabolic risk in women with polycystic ovary syndrome.
    Rasool SUA; Ashraf S; Nabi M; Rashid F; Fazili KM; Amin S
    Diabetes Metab Syndr; 2019; 13(3):2098-2105. PubMed ID: 31235143
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The relationship between subclinical cardiovascular disease and lipocalin-2 levels in women with PCOS.
    Gencer M; Gazi E; Hacıvelioğlu S; Binnetoğlu E; Barutçu A; Türkön H; Temiz A; Altun B; Vural A; Cevizci S; Kumcular T; Coşar E
    Eur J Obstet Gynecol Reprod Biol; 2014 Oct; 181():99-103. PubMed ID: 25145761
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Association of increased levels of omentin-1 and carotid intima-media thickness with early signs of cardiovascular risk in patients with polycystic ovary syndrome: A prospective case control study.
    Alanya Tosun Ş; Gurbuz T; Cebi A; Tosun A; Gokmen O; Usta M
    J Obstet Gynaecol Res; 2022 Jan; 48(1):169-177. PubMed ID: 34676949
    [TBL] [Abstract][Full Text] [Related]  

  • 65. A study on clinical and sonographic features in obese and nonobese patients with polycystic ovary syndrome.
    Siddiqui IA; Tamimi W; Tamim H; Aleisa N; Adham M
    Arch Gynecol Obstet; 2010 Mar; 281(3):467-71. PubMed ID: 19462174
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Higher metabolic risk with National Institutes of Health versus Rotterdam diagnostic criteria for polycystic ovarian syndrome in Turkish women.
    Anaforoglu I; Algun E; Incecayir O; Ersoy K
    Metab Syndr Relat Disord; 2011 Oct; 9(5):375-80. PubMed ID: 21657888
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Body mass index rather than the phenotype impacts precocious ultrasound cardiovascular risk markers in polycystic ovary syndrome.
    Pandurevic S; Bergamaschi L; Pizzi C; Patton L; Rucci P; Corzani F; Cecchetti C; Pelusi C; Altieri P; Vicennati V; Di Dalmazi G; Fanelli F; Macut D; Pagotto U; Gambineri A
    Eur J Endocrinol; 2021 Jan; 184(1):199-208. PubMed ID: 33112268
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Clinical and biochemical presentation of polycystic ovary syndrome in women between the ages of 20 and 40.
    Liang SJ; Hsu CS; Tzeng CR; Chen CH; Hsu MI
    Hum Reprod; 2011 Dec; 26(12):3443-9. PubMed ID: 21926412
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Polycystic ovary syndrome and obesity do not affect vascular parameters related to early atherosclerosis in young women without glucose metabolism disturbances, arterial hypertension and severe abnormalities of lipid profile.
    Barcellos CR; Lage SH; Rocha MP; Hayashida SA; Baracat EC; Romano A; Brito VN; Marcondes JA
    Gynecol Endocrinol; 2013 Apr; 29(4):370-4. PubMed ID: 23327607
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The relationship of epicardial adipose tissue thickness to clinical and biochemical features in women with polycystic ovary syndrome.
    Aydogdu A; Uckaya G; Tasci I; Baysan O; Tapan S; Bugan B; Serdar M; Akbulut H; Aydogan U; Sonmez A; Aydogdu S; Kutlu M
    Endocr J; 2012; 59(6):509-16. PubMed ID: 22447143
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Association between endothelial dysfunction, epicardial fat and subclinical atherosclerosis during menopause.
    Cabrera-Rego JO; Navarro-Despaigne D; Staroushik-Morel L; Díaz-Reyes K; Lima-Martínez MM; Iacobellis G
    Clin Investig Arterioscler; 2018; 30(1):21-27. PubMed ID: 28939053
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Alterations of cardiometabolic risk profile in polycystic ovary syndrome: 13 years follow-up in an unselected population.
    Aksun S; Sonu NC; Aygun S; Karakulak UN; Mumusoglu S; Yildiz BO
    J Endocrinol Invest; 2024 May; 47(5):1129-1137. PubMed ID: 37930586
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Carotid artery intima-media thickness in polycystic ovary syndrome: a systematic review and meta-analysis.
    Meyer ML; Malek AM; Wild RA; Korytkowski MT; Talbott EO
    Hum Reprod Update; 2012; 18(2):112-26. PubMed ID: 22108382
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Evaluation of insulin resistance in idiopathic hirsutism compared with polycystic ovary syndrome patients and healthy individuals.
    Bonakdaran S; Kiafar B; Barazandeh Ahmadabadi F
    Australas J Dermatol; 2016 Feb; 57(1):e1-4. PubMed ID: 25496462
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The effect of PCOS status on atherosclerosis markers and cardiovascular disease risk factors in young women with vitamin D deficiency.
    Atasayan K; Yoldemir T
    Gynecol Endocrinol; 2021 Mar; 37(3):225-229. PubMed ID: 32996333
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Impact of Autoimmune Thyroiditis on Reproductive and Metabolic Parameters in Patients with Polycystic Ovary Syndrome.
    Ulrich J; Goerges J; Keck C; Müller-Wieland D; Diederich S; Janssen OE
    Exp Clin Endocrinol Diabetes; 2018 Apr; 126(4):198-204. PubMed ID: 29506313
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Regional Variation in Hormonal and Metabolic Parameters of White and Black Women With PCOS in the United States.
    VanHise K; Chan JL; Wertheimer S; Handelsman RG; Clark E; Buttle R; Wang ET; Azziz R; Pisarska MD
    J Clin Endocrinol Metab; 2023 Feb; 108(3):706-712. PubMed ID: 36218376
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Evaluation of Carotid Artery Intima-Media Thickness as a Cardiovascular Risk Factor in Patients With Polycystic Ovary Syndrome.
    Yalcin Bahat P; Özel A; Demirci A
    Cureus; 2021 Jan; 13(1):e13025. PubMed ID: 33542889
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Diagnostic value of prostatic specific antigen in hirsute women.
    Güllü S; Emral R; Asik M; Cesur M; Tonyukuk V
    J Endocrinol Invest; 2003 Dec; 26(12):1198-202. PubMed ID: 15055472
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Sonographic measurement of mesenteric fat predicts presence of fatty liver among subjects with polycystic ovary syndrome.
    Ma RC; Liu KH; Lam PM; Cheung LP; Tam WH; Ko GT; Chan MH; Ho CS; Lam CW; Chu WC; Tong PC; So WY; Chan JC; Chow CC
    J Clin Endocrinol Metab; 2011 Mar; 96(3):799-807. PubMed ID: 21190980
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.